Pfizer petitions FDA for approval to use COVID-19 vaccine on 12- to 15-year-old children – Boston 25 News

The nation could be one step closer to getting children protected against COVID-19.
>> Read more trending news
Pharmaceutical company Pfizer filed a request with the FDA to amend its emergency use authorization to allow it to be used on children aged 12 to 15.
Currently, its allowed to be used by anyone age 16 and older.
These requests are based on data from the pivotal Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection which demonstrated 100…

Click here to view the original article.